United States Biotechnology & Medical Research

PharmaCyte Biotech Inc (PMCB)

Track

Track

Ticker: PMCB Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for PharmaCyte Biotech Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
2.3
Silverman Joshua CEO and President Executive Director
Transaction date
Purchase
Price
337.82
Quantity 69,997 +10.8%
Value US$4,689,102
1.6
SCHECHTER JONATHAN Non-Executive Director
Transaction date
Purchase
Price
238.73
Quantity 56,962 +25.1%
Value US$1,035,932
2.3
Silverman Joshua CEO and President Executive Director
Transaction date
Purchase
Price
434.25
Quantity 75,808 -37.8%
Value US$1,472,386
1.6
SCHECHTER JONATHAN Non-Executive Director
Transaction date
Purchase
Price
0.79
Quantity 20,000 +13.1%
Value US$15,808
2.3
Silverman Joshua CEO and President Executive Director
Transaction date
Purchase
Price
0.78
Quantity 30,000 +9.5%
Value US$23,493
1.6
SCHECHTER JONATHAN Non-Executive Director
Transaction date
Purchase
Price
0.78
Quantity 20,000 +15.1%
Value US$15,552
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-01-07 2026-01-07 B Purchase
2.3
Silverman Joshua

CEO and President

Executive Director
69,997 +10.8%
337.82
US$4,689,102 		69,997 +10.8% 337.82 US$4,689,102
2026-01-07 2026-01-07 B Purchase
1.6
SCHECHTER JONATHAN
Non-Executive Director
56,962 +25.1%
238.73
US$1,035,932 		56,962 +25.1% 238.73 US$1,035,932
2026-01-07 2026-01-06 B Purchase
2.3
Silverman Joshua

CEO and President

Executive Director
75,808 -37.8%
434.25
US$1,472,386 		75,808 -37.8% 434.25 US$1,472,386
2026-01-07 2026-01-06 B Purchase
1.6
SCHECHTER JONATHAN
Non-Executive Director
20,000 +13.1%
0.79
US$15,808 		20,000 +13.1% 0.79 US$15,808
2026-01-07 2026-01-05 B Purchase
2.3
Silverman Joshua

CEO and President

Executive Director
30,000 +9.5%
0.78
US$23,493 		30,000 +9.5% 0.78 US$23,493
2026-01-07 2026-01-05 B Purchase
1.6
SCHECHTER JONATHAN
Non-Executive Director
20,000 +15.1%
0.78
US$15,552 		20,000 +15.1% 0.78 US$15,552
Explore more

More insider trading research around PharmaCyte Biotech Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America